24-07-2017 23:14 via rocketnews.com

BRIEF-Interleukin genetics says adoption plan to wind-up and liquidate company subject to shareholder approval via a proxy statement

* Interleukin Genetics Inc – adoption plan to wind-up andliquidate company subject to shareholder approval via a proxystatement
The post BRIEF-Interleukin genetics says adoption plan to wind-up and liquidate company subject to shareholder approval via a proxy statement appeared first on RocketNews | Top News Stories From Around the Globe.
Read more »